acetylshikonin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Z; Gu, T; Jin, G; Liu, K; Lu, N; Mangaladoss, F; Qiao, Y; Tian, X; Zhao, R; Zhao, S | 1 |
1 other study(ies) available for acetylshikonin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19.
Topics: Animals; Anthraquinones; COVID-19; Disease Models, Animal; Mice; Papain | 2022 |